Pfizer accused of Covid-19 vaccine patent infringement again, this time by Arbutus and Genevant
Arbutus has accused Pfizer and BioNTech of infringing its lipid nanoparticle technology patents in developing their blockbuster mRNA Covid-19 vaccine.
While Arbutus and Genevant Sciences (partially owned by Arbutus and Vivek Ramaswamy’s Roivant) acknowledged that Pfizer and BioNTech created and manufactured their vaccine “at a speed unprecedented in the history of medicine,” the plaintiffs argued in a lawsuit filed Tuesday that the feat wouldn’t have been possible without technology invented by Arbutus scientists “years before.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.